0001367644-24-000008.txt : 20240227 0001367644-24-000008.hdr.sgml : 20240227 20240227202640 ACCESSION NUMBER: 0001367644-24-000008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240221 FILED AS OF DATE: 20240227 DATE AS OF CHANGE: 20240227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LINDAHL RICHARD S CENTRAL INDEX KEY: 0001196632 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 24689667 MAIL ADDRESS: STREET 1: NEXTEL STREET 2: 2001 EDMUND HALLEY DR CITY: RESTON STATE: VA ZIP: 20191 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: 240-631-3200 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 4 1 wk-form4_1709083590.xml FORM 4 X0508 4 2024-02-21 0 0001367644 Emergent BioSolutions Inc. EBS 0001196632 LINDAHL RICHARD S 400 PROFESSIONAL DRIVE, SUITE 400 GAITHERSBURG MD 20879 0 1 0 0 EVP, Chief Financial Officer 0 Common Stock 2024-02-21 4 D 0 4012 2.71 D 168980 D Common Stock 2024-02-23 4 F 0 517 2.74 D 168463 D Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA margin calculated on a cumulative basis over the three-year period beginning January 1, 2021 and ending December 31, 2023, as certified by the Compensation Committee following the performance period. On February 21, 2024, the final certification date, the Compensation Committee certified the achievement of the 2021-2023 PSUs at a payout factor of 0.00% of target resulting in the actual award of 0 shares of common stock, which is below the 4,012 shares previously reported on February 24, 2021. Represents shares of common stock withheld to pay taxes. This Form 4 was filed late due to an inadvertent administrative error. The Company will report all late Form 4s in its next proxy statement /s/ Jennifer Lynne Fox, Attorney-in-fact 2024-02-27